Kisolite Health
The business, the turning points, and the decisions behind them.
Some sections are still being researched2 / 4
Sections to complete：02 · 05
01 / WHAT IT BUILT
What the company did
Kisolite Corp, a privately held Canadian biotechnology company founded in 2018, commercializes a natural bioactive mineral product called Kisolite, a glacial clay sourced from the Kisameet Bay deposit in British Columbia. Produced at a GMP-compliant facility in Squamish, the mineral clay is marketed as an active ingredient for pharmaceutical dermatology and consumer skin-health products, with reported anti-inflammatory and immunomodulatory effects. The company raised $250,000 in a January 2025 securities filing.
02 / FAILURE REASONS
Material for this section is being gathered and checked. It will appear here once ready.
03 / EVENT HISTORY
Events in the structured record
- Company founded
Kisolite Corp is founded in British Columbia to commercialize the Kisameet Bay glacial clay.
- Funding round
The company raises $250,000 in an offering filed in January 2025, per SEC Form D.
04 / CONTEMPORARY REBUILD ASSESSMENT
Difficulty of rebuilding this project today
Material for this section is being gathered and checked. It will appear here once ready.
Overall assessment: Not completed
05 / CAUSAL CHAIN / AFTERMATH
Material for this section is being gathered and checked. It will appear here once ready.